Job offer > Joboolo FR :

Psychological sciences » Cognitive science

Organisation/Company:


Université Paris Cité

Research Field:


Psychological sciences, Neurosciences, Cognitive science

Researcher Profile:


First Stage Researcher (R1)

Positions:


PhD Positions

Country:


France

Application Deadline:


30 May 2025

- 12:


30 (Europe/Paris)

Type of Contract:


Temporary

Job Status:


Full-time

Hours Per Week:


40

Offer Starting Date:


1 Sep 2025

Is the job funded through the EU Research Framework Programme?
Horizon Europe

- MSCA Marie Curie Grant Agreement Number 101169266

Is the Job related to staff position within a Research Infrastructure?
No

The ENTRY-DM Doctoral Network, funded under the prestigious Marie Sk?odowska-Curie Actions – Doctoral Networks (MSCA-DN) programme, is offering 14 fully funded PhD positions across leading European institutions.

ENTRY-DM is an ambitious interdisciplinary and intersectoral training programme that will equip the next generation of researchers with the expertise to develop novel oligonucleotide-based therapies for myotonic dystrophy.


This programme brings together leading academic institutions, innovative biotech companies, and patient advocacy groups, forming a unique collaborative environment for doctoral training at the intersection of fundamental science, translational medicine, and clinical application.

Myotonic dystrophy (DM) is the most common inherited muscular dystrophy in adults.


It is a complex multi-systemic disorder, impacting not only skeletal and cardiac muscle but also the nervous system, among others.


Despite recent advances in understanding the genetic and molecular mechanisms of DM, no effective treatment is currently available.

ENTRY-DM aims to transform the therapeutic landscape for DM by training a new generation of creative PhD researchers in a structured, interdisciplinary research programme.


The project will focus on three major research objectives:


(1) development of innovative disease models and exploring disease mechanisms, (2) optimising ASO-based therapies, and (3) defining clinical biomarkers for clinical trials.

Candidate’s Profile:

We are looking for a highly motivated and ambitious doctoral candidate with clinical/cognitive neuropsychological or health psychology and/or neurosciences background.


A strong interest in neuromuscular disorders and adult decision-making cognition is essential.


Applicants must hold a MSc (or equivalent) in Psychological Sciences, Health Psychology or Clinical Neurosciences.


Hands-on experience with quantitative research design, neuropsychological testing and advanced statistical methods is required.

Anticipated secondments for this position are:

1. EU Clinical Research Infrastructure Network, Christine Kubiak (Paris, France).


2. University of Gothenburg, Stefan Winblad (Gothenburg, Sweden).

Eligibility criteria

• MSc degree:
  
  
  Candidates must hold a Master’s degree (or equivalent) in biology, biomedicine, neuroscience, chemistry, bioengineering, or related fields.
  
  
  Candidates must not have been awarded a previous PhD degree.


• Trans-national mobility:
  
  
  The applicant must have not resided in the country where the research training takes place for more than 12 months in the 3 years immediately prior to recruitment.


• English proficiency:
  
  
  Applicants must have excellent English proficiency, at least B2 level (written and spoken).

• Cutting-edge research training in oligonucleotide-based therapies for rare diseases.


• First-hand experience in translational research, working across biology, chemistry, bioengineering, computational biology, and clinical research.


• International, interdisciplinary, and intersectoral mobility, with secondments across Europe and USA.


• Joint supervision by leading experts from academia, industry, and clinical sectors.


• Participation in international conferences, workshops, and transferable skills training.


• Competitive salary and allowances following MSCA-DN funding rules.